Celcuity Inc (FRA:7VR)
€ 73.5 +1 (+1.38%) Market Cap: 3.85 Bil Enterprise Value: 3.79 Bil PE Ratio: 0 PB Ratio: 81.40 GF Score: 11/100

Celcuity Inc at Goldman Sachs Healthcare Conference Transcript

Jun 10, 2026 / 12:00 PM GMT
Release Date Price: €75.5 (+5.59%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CELC.OQ - Celcuity Inc
Celcuity Inc at Goldman Sachs Healthcare Conference
Jun 10, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, let's kick off our next session.

Good morning, everyone.

I am very excited to hold Selkuity.

And with me is Brian Sullivan, CEO and co-founder of the company.

We have a lot to go do, a lot happening in the company. But before we get there. I'm going to turn it to you for opening remarks.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Oh, sure. So I guess the most important thing to understand about Cellcuity is that we're focused on treating diseases that involve the PI3K AKT mTOR pathway, which we refer to as the PAM pathway.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot